Historical catalog analysis: CISA added this entry on June 11, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.
What the vulnerability is
CVE-2026-10520 is an OS command injection vulnerability affecting Ivanti Sentry (formerly MobileIron Sentry). This flaw allows a remote, unauthenticated actor to achieve root-level remote code execution on the appliance. Because these appliances manage mobile devices used by clinicians and staff to access electronic protected health information (ePHI), a compromise of the management infrastructure could potentially jeopardize the security of the entire mobile endpoint fleet.
Exposure and applicability
This vulnerability is not universal to all Ivanti Sentry installations. It specifically applies to environments where the Sentry appliance is in an “unmanaged state” and its endpoints are externally reachable.
Conversely, certain configurations provide inherent protection by making interfaces inaccessible to external actors. These include:
* The use of mutual TLS (mTLS) with EPMM.
* Restricted HTTPS access implemented through Neurons for MDM.
Due to the risk of root-level access, CISA added this vulnerability to its Known Exploited Vulnerabilities (KEV) catalog on June 11, 2026.
Remediation priorities
Our analysis suggests that healthcare IT and security leaders prioritize remediation based on their specific deployment architecture. We recommend the following actions:
- Configuration Audit: Immediately determine if Sentry appliances are in an “unmanaged state” and verify if they are reachable from the public internet. This is a prerequisite for exploitation.
- Apply Vendor Mitigations: For vulnerable configurations, apply the mitigations provided by Ivanti to address the command injection flaw.
- Restrict Network Access: If not already implemented, transition toward restricted HTTPS access via Neurons for MDM or mTLS with EPMM to reduce the external attack surface.
How to validate remediation
To verify that the risk has been reduced, administrators should focus on connectivity and configuration state rather than just version numbers. Validation evidence could include:
* Network Reachability Tests: Confirming via firewall logs or network scanning that Sentry interfaces are no longer externally reachable or are restricted to authorized tunnels.
* Configuration Verification: Documenting the transition from an “unmanaged state” to a managed state as defined by vendor documentation.
* Authentication Checks: Verifying that mTLS is strictly enforced for all external connections to the appliance.
Limits and open questions
While applying vendor mitigations can reduce the likelihood of exploitation, it may not guarantee total immunity from all threats targeting MDM infrastructure. It remains unknown whether this specific vulnerability has been utilized in ransomware campaigns. Additionally, while CISA has set a remediation deadline for federal agencies, private healthcare providers must determine their own patching urgency based on their internal risk appetite and the criticality of the managed clinical devices.
Source and editorial note
CVE-2026-10520: Ivanti Sentry OS Command Injection Vulnerability · Source date: June 11, 2026 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Archive date: June 14, 2026. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: September 06, 2026 at 03:15 UTC.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗